Oculis Holding AG (OCS) Return on Capital Employed (2023 - 2026)
Quarterly Return on Capital Employed rose 2.0% to 0.44% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.44% through Mar 2026, up 2.0% year-over-year, with the annual reading at 0.88% for FY2025, 7.0% down from the prior year.
Oculis Holding AG's Return on Capital Employed history spans 4 years, with the latest figure at 0.44% for Q1 2026.
- Return on Capital Employed came in at 0.44% for Q1 2026, down from 0.56% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.99% in Q1 2024 to a low of 0.36% in Q2 2025.
- The 4-year median for Return on Capital Employed is 0.58% (2024), against an average of 0.63%.
- Year-over-year, Return on Capital Employed crashed -56bps in 2025 and then rose 2bps in 2026.
- Oculis Holding AG's Return on Capital Employed stood at 0.85% in 2023, then plummeted by -31bps to 0.58% in 2024, then fell by -5bps to 0.56% in 2025, then fell by -20bps to 0.44% in 2026.
- Per Business Quant, the three most recent readings for OCS's Return on Capital Employed are 0.44% (Q1 2026), 0.56% (Q4 2025), and 0.37% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 21.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.19% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.34% |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | 0.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.44% |
| Dec 31, 2025 | 0.56% |
| Sep 30, 2025 | 0.37% |
| Jun 30, 2025 | 0.36% |
| Mar 31, 2025 | 0.43% |
| Dec 31, 2024 | 0.58% |
| Sep 30, 2024 | 0.63% |
| Jun 30, 2024 | 0.92% |
| Mar 31, 2024 | 0.99% |
| Dec 31, 2023 | 0.85% |
| Sep 30, 2023 | 0.81% |